PATENT CLAIM ANALYSIS

Application Number: 16009308
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "161000"]

Abstract:
Disclosed is a compound of Formula 1, and a pharmaceutically acceptable salt thereof. This disclosure also relates to materials and methods for preparing the compound of Formula 1, to pharmaceutical compositions which contain it, and to its use for treating diseases, disorders, and conditions associated with GPR6.

Claim (Index 19):
The combination therapy of  claim 15 , wherein the additional pharmacologically active agent is selected from the group consisting of: beta-secretase inhibitors, gamma-secretase inhibitors, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.42105
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15979069', '15118461', '15621761', '15334198', '14577480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7989492080014773
- 35 USC 102 Novelty (BERT): 0.50174863127547
- Combined Prediction Score: 0.7692291503288766
- Mean Citation Score: 210.882644
- Max Citation Score: 219.74248
- Similarity Product: 138.4969104410267

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test